pathology microbiology and immunology
-
June 11, 2015
Medical societies honor VUMC’s Cover, Williams
Two physicians from Vanderbilt University have been elected to membership in two of the nation’s oldest and most respected medical honor societies — the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI). -
June 4, 2015
Study identifies C. diff toxin receptor, suggests new treatment approaches
Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States. -
May 4, 2015
Kids more likely to react to blood transfusions
Pediatric patients have a significantly higher incidence of transfusion reactions compared to adults, according to a study by Vanderbilt University researchers. -
April 30, 2015
RNA defects in multiple sclerosis
Vanderbilt researchers have discovered that profound defects exist in the integrity of structural RNA molecules in patients with relapsing remitting multiple sclerosis. -
April 16, 2015
Cates lands grant to study desmoid tumor genetic factors
The Desmoid Tumor Research Foundation (DTRF) has awarded Justin Cates, M.D., Ph.D., associate professor of Pathology, Microbiology and Immunology, with one of its five research grants for his work studying growth/recurrence determinants related to genetic factors in desmoid-type fibromatosis (DTF) patients. -
February 24, 2015
Contributors to coronavirus ‘fitness’
Understanding the role that host membrane modification plays in coronavirus replication is essential for developing novel approaches to block the viruses that cause SARS and MERS. -
February 10, 2015
Targeting HIV’s “cap”
New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target.